Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: A Danish nationwide cohort study.
Event:
ESC Congress 2017
Topic:
Atrial fibrillation (AF)
Session:
Stroke prevention
